INTRODUCTION
The lymphatic system consists of capillaries that uptake interstitial fluid and of collecting ducts that transport the fluid back into the bloodstream. Intraluminal valves in lymphatic collecting ducts ensure unidirectional flow. Mature lymphatic valves are made up of two leaflets that consist of an extracellular matrix (ECM) core surrounded by specialized valve lymphatic endothelial cells (LECs). In mice, lymphatic valve formation begins at embryonic day 15.5 (E15.5). LECs expressing high levels of the transcription factors Prox1 (Prox1 high ) and Foxc2 cluster at putative valve sites, distinguishable from ductal LECs that express low Prox1 (Prox1 low ). Connexin 37 (Cx37; Gja4 -Mouse Genome Informatics) is induced in clustered LECs and is required for proper valve morphogenesis (Kanady et al., 2011; Sabine et al., 2012) . The Prox1 high LECs organize into a ring-like structure that constricts the collecting duct, and then valve LECs invaginate into the lumen (Sabine et al., 2012) . A valve leaflet ECM core consisting of laminin α5, collagen IV and fibronectin-EIIIA (FNEIIIA) is formed by the invaginating LECs, enabling leaflet elongation and maturation (Bazigou et al., 2009; Norrmen et al., 2009) .
Molecular regulators of valve initiation and maturation are beginning to be understood. Genes encoding the lymphatic proteins Prox1, Foxc2, integrin α9, FNEIIIA and Cx37 are all highly expressed in lymphatic valves (Bazigou et al., 2009; Kanady et al., 2011; Norrmen et al., 2009; Petrova et al., 2004; Sabine et al., 2012) . Calcineurin signaling and Cx37 are required to specify the sites of valve formation in the duct wall (Sabine et al., 2012) . Interaction of integrin α9 with its ligand FNEIIIA allows for proper valve leaflet ECM core assembly and leaflet elongation. Cx37 is thought to help coordinate the valve-forming LECs into an organized valve structure (Bazigou et al., 2009; Sabine et al., 2012) .
Notch signaling requires direct cell-cell contact between Notch ligand-presenting cells and receptor-expressing cells, and regulates cell-fate determination (Andersson et al., 2011) . Ligandinduced proteolytic cleavage releases the Notch intracellular domain that translocates to the nucleus where it forms a transcriptional activation complex with CSL, Mastermind-like and co-activators (Borggrefe and Liefeke, 2012) . Notch regulates lymphatic sprouting events in physiological and pathological settings (Niessen et al., 2011; Zheng et al., 2011) . We have shown that Notch functions in embryonic venous endothelium to restrict the number of venous ECs that adopt the lymphatic fate (Murtomaki et al., 2013) .
Notch mediates bi-potential cell fate decisions in multiple biological settings. Valve LECs must be specified from ductal LECs. We hypothesized that Notch may function in this process. Notch1 expression and Notch activation were observed in the valve-forming LECs. We used the Prox1CreER T2 -inducible driver (Srinivasan et al., 2007) to delete Notch1 or to inhibit Notch signaling by expressing a dominant-negative Mastermind-like transgene (Tu et al., 2005) in LECs at the initiation of valve formation. Lymphatic endothelial-specific loss of Notch1 or Notch signaling resulted in abnormal Prox1 high -Prox1 low expression pattern, abnormal valve morphology and reduced integrin α9 and FNEIIIA expression in valve LECs. In human dermal lymphatic endothelial cells (HdLECs), Notch1 or Notch4 activation induced integrin α9, FNEIIIA and Cx37. We report a novel role for Notch in lymphatic valve formation through its regulation of the Prox1 high/low expression pattern, and integrin α9 and FNEIIIA expression.
RESULTS AND DISCUSSION Notch1 expression and Notch activity became enriched in lymphatic valves
Notch1 expression was analyzed in embryonic mesenteric lymphatics. At E16.5, Notch1 was uniformly expressed in the mesenteric collecting lymphatic ductal endothelium (Fig. 1A) . At E17.5, Notch1 expression was highest in the Prox1 high LECs at putative valve sites (Fig. 1A) . By E18.5, Notch1 expression was enriched in valve-forming LECs and weak Notch1 expression was seen in the collecting duct LECs (Fig. 1A, supplementary  material Fig. S1 ). Notch1 expression was observed in adjacent blood vessels and capillaries.
We assessed Notch signaling in mesenteric lymphatic vessels using the transgenic Notch reporter mouse (TNR), which expresses GFP in response to CSL-dependent Notch signaling. TNR mesenteries were stained for GFP and the lymphatic marker, vascular endothelial growth factor receptor 3 (VEGFR3) or integrin α9 (α9). At E17.5, Notch signal activation was seen in clusters of cells at the putative valve sites (Fig. 1B) . LECs in the developing collecting ducts and blood vessels adjacent to the ducts also expressed GFP (data not shown). At E18.5, GFP expression was mainly detected in the α9-positive LECs of the lymphatic valves (Fig. 1B) Fig. 2A,B ). The regions of Prox1 high LECs were expanded in LOF mesenteric lymphatics ( Fig. 2A ). There was a significant increase in the number of Prox1 high LECs normalized to ductal length in LOF mesenteric lymphatics compared with controls ( Fig. 2D) fl/fl and control mesenteric lymphatics (data not shown). However, the LOF valve leaflets were poorly organized (Fig. 2C) . Formation of the lymphatic valve leaflets requires α9 and its ligand FNEIIIA (Bazigou et al., 2009) . Prox1 high cells of control mesenteric valves expressed α9 and FNEIIIA (Fig. 2C) . By contrast, α9 expression was significantly lower in the LOF Prox1 high LECs that had migrated into the lumen (Fig. 2F) , suggesting that Notch1 regulates α9 expression in valve LECs. Clusters of valve-forming LECs were also reduced in the dermal lymphatics of LOF embryos (supplementary material Fig. S3 ).
The increase in the number of Prox1 high LECs suggests that Notch1 functions to restrict the number of LECs that go on to become Prox1 high . Notch1 may also function to cluster the Prox1 high cells at sites of valve formation. Even when Prox1 high LOF LECs had clustered, the cells failed to reorient and failed to express α9. The abnormal valve leaflets in the LOF mice had a phenotype similar to that described for Cx37 mouse mutants (Kanady et al., 2011; Sabine et al., 2012) .
Loss of canonical Notch signaling severely disrupted valve formation and reduced FNEIIIA expression
We speculated that additional Notch proteins compensate for the loss of Notch1, partly based upon incomplete loss of FNEIIIA observed in the LOF valves. We addressed this hypothesis using a transgenic mouse line to express a dominant-negative Mastermindlike1/GFP fusion protein (DNMAML) (Tu et al., 2005) in Prox1-expressing LECs. DNMAML forms an inactive complex with Notch to inhibit canonical Notch/CSL signaling downstream of all Notch proteins without affecting CSL repressor function. DNMAML fl/fl mice were crossed with the Prox1CreER T2 driver, tamoxifen was administered at E13.5 or E15.5, and mesenteries were collected at E18.5. GFP expression was detected in Prox1CreER T2 ;DNMAML fl/ + mesenteric lymphatics (supplementary material Fig. S4 ), but not in control (DNMAML fl/+ ) mesenteries (data not shown). Prox1CreER T2 ;DNMAML fl/+ valve morphogenesis phenotype was more severe (Fig. 3) than the Prox1CreER T2 ;N1 fl/fl phenotype (Fig. 2) . Control mesenteries displayed the expected Prox1 highProx1 low pattern, with Prox1 high LECs clustering at putative valve sites (Fig. 3A,B) . Tamoxifen administration at E13.5 or E15.5 disrupted this pattern (Fig. 3A,B control valve LECs (Fig. 3A,B) . The overall number of Prox1 high , α9 and FNEIIIA triple-positive valves per duct was significantly reduced in Prox1CreER T2 ;DNMAML fl/+ mesenteries compared with controls (Fig. 3E) . Many of the Prox1CreER
T2
;DNMAML fl/+ mesenteric lymphatics had no identifiable lymphatic valves (Fig. 3C) . When putative valves were observed in Prox1CreER T2 ; DNMAML fl/+ lymphatics, the valves were disorganized and usually expressed only one of two valve markers, α9 or FNEIIIA (Fig. 3C) . FNEIIIA expression in Prox1 high valve LECs was absent in Prox1CreER T2 ;DNMAML fl/+ mutants compared with controls (Fig. 3F) . A significant loss of α9 expression was not achieved, largely owing to an insufficient number of identifiable valves that could be analyzed, suggesting that valve initiation was disrupted in the absence of α9 expression. As expected, α9 expression by smooth muscle cells around arteries and was not affected in Prox1CreER T2 ; DNMAML fl/+ mesenteries (Fig. 3C ). α9 and its ligand FNEIIIA are indispensable for valve leaflet formation (Bazigou et al., 2009) . As α9 and FNEIIIA expression is lost in Notch signaling-deficient mesenteries with defective valves, we propose that Notch functions in valve morphogenesis by inducing expression of these proteins in valve LECs. Furthermore, the disruption of Prox1 expression pattern in Prox1CreER We sought to determine whether Notch regulates the expression of valve genes, α9, FNEIIIA, Cx37, calcineurin and Foxc2.
HdLECs were infected with an adenovirus encoding a constitutively active Notch1 intracellular domain (N1IC), a constitutively active allele of Notch4 (N4int3), lacZ or GFP (Shawber et al., 2007; Tung et al., 2009 ). N1IC or N4int3 induced α9 transcripts (Fig. 4A) , whereas only N1IC increased α9/β1 surface expression (Fig. 4A) . The absence of increased α9 surface in N4int3-expressing HdLECs may be due to its reduced activity relative to N1IC (supplementary material Fig. S5 ). The transcriptional repressors Hey1 and Hey2 did not affect α9 levels, suggesting that α9 is a direct target of Notch transcriptional activation or regulated indirectly by other Notch-induced proteins.
Mammalian fibronectin consists of various isoforms, created through alternative splicing (Muro et al., 2003) . FNEIIIA splice variant is expressed in the developing lymphatic valve ECM core (Bazigou et al., 2009 ). We evaluated transcript and protein levels for fibronectin with (FN-EIIIA+) or without (FN-EIIIA−) the EIIIA domain. Expression of N1IC or N4int3 increased levels of FN-EIIIA+ and FN-EIIIA− transcripts, and of total fibronectin and FN-EIIIA+ proteins (Fig. 4B) . The antibody used to detect total fibronectin recognizes FN-EIIIA+ and FN-EIIIA− proteins, thus the increase in total fibronectin levels may be due to increased FN-EIIIA+ levels or to a combination of increased FN-EIIIA+ and FN-EIIIA− levels.
N1IC or N4int3 strongly induced Cx37 transcripts and protein in HdLECs (Fig. 4C) . As Cx37 is required for reorientation of Prox1 high LECs and lymphatic valve formation (Kanady et al., 2011; Sabine et al., 2012) , the reorientation phenotype in the LOF models may be due to a reduction in Cx37 expression. Expression of N1IC or N4int3 modestly induced Foxc2 transcripts 1.5-fold (supplementary material Fig. S6A ), whereas the calcineurin subunit Cnb1 was unaffected by Notch activation (supplementary material Fig. S6B) . 
MATERIALS AND METHODS

Mouse lines
Prox1CreER
T2 (Srinivasan et al., 2007) , Notch1 fl/fl (Yang et al., 2004) and DNMAML (Tu et al., 2005) mice have been described previously. Notch1 fl/fl , ROSA:LacZ fl/fl and TNR mice were from Jax Labs. Tamoxifen in corn oil was administered via oral gavage or intraperitoneal injection (10 mg/40 g) to females at E13.5 or E15.5. Two to six litters were analyzed for each time-point.
Immunohistochemistry
Mesenteries collected at E16.5, E17.5 and E18.5 were fixed in 4% paraformaldehyde, blocked in 5% donkey serum, 0.2% BSA, 0.5% Triton-X100 and PBS, and incubated overnight with primary antibodies (supplementary material Table S1 ). Mesenteries were washed, incubated with secondary Alexa Fluor antibodies (Invitrogen) diluted in 0.2% BSA, 0.3% Triton-X100 and PBS, and washed and mounted with Vectashield with DAPI (Vector Labs). MOM kit (Vector Labs) was used with mouse monoclonal antibodies. Images were acquired using a laser scanning confocal Zeiss LSM 510 Meta microscope and LSM software, or a Nikon A1 confocal microscope and NIS Elements software.
Constructs and cell culture
HdLECs isolated from human neonatal foreskins (Columbia IRBAAAB-1700) were maintained in EGM-2MV BulletKit (Lonza) with VEGFC (10 ng/ml, RnD) (Murtomaki et al., 2013) . HdLECs were infected with adenovirus expressing constitutively active Notch1 (N1IC) or Notch4 (N4int3), or Hey1, Hey2, lacZ or GFP (Shawber et al., 2007; Tung et al., 2009) . Expression verified by qRT-PCR and/or western blot analyses.
RT-PCR, western blots and flow cytometry
HdLEC were assessed 48 h after adenoviral infections. RNA was isolated (RNeasy Mini Kit, Qiagen) and cDNA synthesized (Verso cDNA synthesis kit, Fisher). qPCR performed with Sybr Green Master Mix (ABI) or Absolute Blue qPCR SYBR Green ROX Mix (Fisher) using 7300 Real-Time PCR System (ABI). Gene-specific PCR products cloned into pDrive (Stratagene) served as standards. β-Actin was used to normalize qRT-PCRs. Protein was isolated in TENT lysis buffer (Shawber et al., 2007) and westerns were performed. HdLECs were incubated with anti-integrin α9β1 antibody (abcam), followed by antirabbit-APC (Jackson Immunoresearch). Ten-thousand cells per group were counted using FACSCalibur and CellQuestPro acquisition software (BD Biosciences). Antibody and primer details can be found in supplementary material Tables S1 and S2 .
Statistical analysis
Image J used to quantitate phenotypes. Number of embryos and images analyzed summarized in supplementary material high clusters reorienting at least 45°to the duct wall was determined. Number of Prox1/α9/FNEIIIA triple-positive valves determined per duct. α9-and FNEIIIA-positive signal was normalized to Prox1 high signal at site of valve formation. Significance determined using two-tailed Student's t-test. In vitro data represents three or more independent experiments.
